At the news
? NEUTRALIMPACT 3/10 DEFA14A filed Apr 29, 2026 at 16:25 ET
MiMedx Group filed a DEFA14A (additional definitive proxy soliciting materials). The substantive content of the filing is unavailable as only cover page and encoded graphic images were provided. The filing follows an April 16 8-K announcing a cost reduction initiative expected to generate $40 million in annualized savings, including elimination of the COO role. Without readable proxy content, the specific proposals or solicitation matters cannot be determined.
- Filing type: DEFA14A (additional definitive proxy soliciting materials)
- Filed April 29, 2026, following an April 16, 2026 8-K announcing cost reduction and executive changes
- Prior 8-K projected $40 million in annualized savings and a one-time $4 million restructuring charge
- Proxy statement content (definitive additional materials) not available in parsed text form
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access